Back to Board of Directors
Angela F. Braly - Former Chair of the Board, President and Chief Executive Officer of WellPoint, Inc. (now known as Elevance Health)

Independent Director since:
2009

Other Public Company Boards:
ExxonMobil Corp. (since 2016), Brookfield Corporation (since 2015), Lowe’s Companies (2013 to 2021)

Committees:
Governance & Public Responsibility (Chair), Audit

Age as of Most Recent Nomination:
62

Angela F. Braly

Former Chair of the Board, President and Chief Executive Officer of WellPoint, Inc. (now known as Elevance Health)

Ms. Braly is the former Chair of the Board, President and Chief Executive Officer of WellPoint, Inc. (healthcare insurance), now known as Elevance Health. She served as Chair of the Board from 2010 to 2012 and as President and Chief Executive Officer from 2007 to 2012.

She previously served as Executive Vice President, General Counsel, and Chief Public Affairs Officer of WellPoint from 2005 to 2007, and President and Chief Executive Officer of Blue Cross Blue Shield of Missouri from 2003 to 2005. Ms. Braly is also a co-founder of The Policy Circle, a nonprofit organization promoting civic engagement and public policy thought leadership among women.

SKILLS & QUALIFICATIONS

Ms. Braly’s diverse Leadership, Strategy, and Risk Management experience at WellPoint enables her to provide valuable insight about risk management and governance matters, particularly as it pertains to the Consumer Industry/Retail sector, to the Board.

Additionally, her role as General Counsel and Chief Public Affairs Officer for WellPoint, where she was responsible for the company’s government relations, public policy development, social responsibility, and corporate governance initiatives; her experience on other public company boards; and her ongoing engagement in public policy matters enable her to bring significant Corporate Governance expertise and Regulatory and Public Policy skills to the Board.

In particular, her experience leading WellPoint during the significant industry and regulatory transformation driven by the Affordable Care Act enables her to provide additional insight and perspective on regulatory and policy impacts.

Further she has been engaged in oversight of the Company’s efforts across Environmental Sustainability, drawing upon her prior and current service as chair or member of multiple external board committees with responsibility for oversight of topics such as climate and emissions, safety, and environmental matters.